Kaveri Pohlman
Stock Analyst at Clear Street
(1.91)
# 3,186
Out of 5,117 analysts
32
Total ratings
41.94%
Success rate
-7.65%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kaveri Pohlman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PALI Palisade Bio | Initiates: Buy | $12 | $2.10 | +471.43% | 1 | Dec 30, 2025 | |
| GPCR Structure Therapeutics | Maintains: Buy | $61 → $99 | $62.77 | +57.72% | 1 | Dec 9, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $200 | $88.44 | +126.14% | 1 | Dec 5, 2025 | |
| JANX Janux Therapeutics | Maintains: Buy | $80 → $32 | $13.75 | +132.73% | 2 | Dec 2, 2025 | |
| JBIO Jade Biosciences | Initiates: Buy | $25 | $13.12 | +90.55% | 1 | Nov 25, 2025 | |
| TRVI Trevi Therapeutics | Maintains: Buy | $11 → $21 | $11.36 | +84.86% | 1 | Nov 14, 2025 | |
| ZURA Zura Bio | Initiates: Buy | $18 | $4.80 | +275.00% | 1 | Nov 13, 2025 | |
| SGMT Sagimet Biosciences | Initiates: Buy | $29 | $5.54 | +423.47% | 1 | Oct 22, 2025 | |
| RAPT RAPT Therapeutics | Maintains: Buy | $41 → $60 | $29.82 | +101.21% | 2 | Oct 21, 2025 | |
| VTYX Ventyx Biosciences | Initiates: Buy | $11 | $7.82 | +40.66% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 | $26.88 | +71.13% | 1 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $19.53 | +63.85% | 1 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.72 | - | 4 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $47 | $31.80 | +47.80% | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $30 | $9.99 | +200.30% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $56 → $38 | $14.27 | +166.29% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $8.59 | -41.79% | 2 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $1.21 | +561.16% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $42.40 | -36.32% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $21.77 | +221.54% | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $3.89 | +208.48% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $8 | $4.12 | +94.17% | 2 | Jul 7, 2022 |
Palisade Bio
Dec 30, 2025
Initiates: Buy
Price Target: $12
Current: $2.10
Upside: +471.43%
Structure Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $61 → $99
Current: $62.77
Upside: +57.72%
Palvella Therapeutics
Dec 5, 2025
Initiates: Buy
Price Target: $200
Current: $88.44
Upside: +126.14%
Janux Therapeutics
Dec 2, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $13.75
Upside: +132.73%
Jade Biosciences
Nov 25, 2025
Initiates: Buy
Price Target: $25
Current: $13.12
Upside: +90.55%
Trevi Therapeutics
Nov 14, 2025
Maintains: Buy
Price Target: $11 → $21
Current: $11.36
Upside: +84.86%
Zura Bio
Nov 13, 2025
Initiates: Buy
Price Target: $18
Current: $4.80
Upside: +275.00%
Sagimet Biosciences
Oct 22, 2025
Initiates: Buy
Price Target: $29
Current: $5.54
Upside: +423.47%
RAPT Therapeutics
Oct 21, 2025
Maintains: Buy
Price Target: $41 → $60
Current: $29.82
Upside: +101.21%
Ventyx Biosciences
Oct 1, 2025
Initiates: Buy
Price Target: $11
Current: $7.82
Upside: +40.66%
Sep 17, 2025
Maintains: Buy
Price Target: $46
Current: $26.88
Upside: +71.13%
Jun 25, 2025
Initiates: Buy
Price Target: $32
Current: $19.53
Upside: +63.85%
Aug 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.72
Upside: -
Jun 27, 2024
Maintains: Buy
Price Target: $46 → $47
Current: $31.80
Upside: +47.80%
Apr 17, 2024
Maintains: Buy
Price Target: $20 → $30
Current: $9.99
Upside: +200.30%
Apr 16, 2024
Maintains: Buy
Price Target: $56 → $38
Current: $14.27
Upside: +166.29%
Mar 26, 2024
Upgrades: Buy
Price Target: $5
Current: $8.59
Upside: -41.79%
Feb 9, 2024
Initiates: Buy
Price Target: $8
Current: $1.21
Upside: +561.16%
Dec 19, 2023
Initiates: Buy
Price Target: $27
Current: $42.40
Upside: -36.32%
Aug 23, 2023
Reiterates: Buy
Price Target: $70
Current: $21.77
Upside: +221.54%
Aug 31, 2022
Initiates: Buy
Price Target: $12
Current: $3.89
Upside: +208.48%
Jul 7, 2022
Maintains: Buy
Price Target: $16 → $8
Current: $4.12
Upside: +94.17%